While using psilocybin mushrooms or LSD can provide enjoyable sensations and useful insights, such trips can sometimes come with uncomfortable effects—including intense grief and fear. But pairing psychedelics with a small dose of MDMA, a new study says, seems to both reduce those feelings of discomfort and highlight more positive aspects of the experience. The […]| Marijuana Moment
A new peer-reviewed study in the journal Nature says treatment with MDMA reduced symptoms in patients with moderate to severe PTSD. The Phase 3 trial findings mean federal regulators could consider approving the drug for wider use as soon as next year, says the Multidisciplinary Association for Psychedelic Studies (MAPS), which sponsored the research. “Thanks […]| Marijuana Moment
Breakthrough Therapy designation is a process designed to expedite the development and review of drugs that are intended to treat a serious condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapy on a clinically significant endpoint(s).| U.S. Food and Drug Administration